Global Botulinum Toxin Market Size, Share & Industry Trends Analysis Report By Product, By Application (Therapeutic and Aesthetic), By End User (Hospitals, Dermatology Clinics and Spas & Cosmetic Centers, By Regional Outlook and Forecast, 2022 - 2028

The Global Botulinum Toxin Market size is expected to reach $10.5 billion by 2028, rising at a market growth of 10.8% CAGR during the forecast period.

Botulinum toxin is a neurotoxin, which is one of the most lethal biological chemicals created by the bacterium Clostridium botulinum. Eight exotoxins with distinct antigens are produced by botulinum C. The main neurotransmitter at the neuromuscular junction, acetylcholine, is blocked by all serotypes, interfering with neuronal transmission and paralyzing muscles. Botulinum toxin A injection-induced weakness often lasts for three months.

Strabismus, focal dystonia, hemifacial spasm, various spastic movement disorders, hyperhidrosis, headaches, hypersalivation, and some chronic conditions that only partially respond to medical treatment are just a few of the many medical conditions that can now be controlled with the help of botulinum toxins. The number of potential new symptoms is growing quickly. Cosmetologically applications as well as dermatological ones, like hyperhidrosis to correcting lines, creases, and wrinkles all over the face, neck, chin, and chest are benefitted with this compound.

Botulinum toxin injections are often well tolerated and have very few adverse effects. To effectively use botulinum toxins in clinical practice, one must possess a thorough understanding and expertise of the functional anatomy of the mimetic muscles. Botulinum toxin, one of the most toxic biological molecules, is also known as miracle poison. This neurotoxin is produced by the anaerobic, gram-positive rod-shaped bacterium Clostridium botulinum, which is typically found on plants, in soil, water, and animal intestinal tracts.

Botulinum toxin type A can effectively treat strabismus in humans. Botulinum toxin was subsequently authorized for the treatment of several spasticity problems as well as a variety of other ailments. It is currently utilized in practically all medical subspecialties. The FDA authorized the cosmetic use of Botox (Botulinum toxin-A) in 2002 to temporarily lessen glabellar forehead frown lines.

COVID-19 Impact Analysis

The demand-supply equilibrium across the whole healthcare sector was severely disrupted by the pandemic. The botulinum toxin market has been considerably impacted due to this abrupt burden on the worldwide healthcare infrastructure. Many cosmetic treatments and operations were initially put on hold as a result of domestic as well as international lockdowns that were imposed in the majority of countries. However, due to the higher demand during the pandemic, sales of botulinum toxins, like Botox, witnessed a spike. Many dermatologists and plastic surgeons attribute the growth to people with the desire to look their best for conferences and online meetings, as well as having more time to attend consultations and recover from treatments.

Market Growth Factors

High Levels Of Effectiveness And Efficiency In Therapeutic And Cosmetic Applications

Botulinum toxin is considered to be primarily utilized to treat cosmetic diseases, however, its medicinal uses go far beyond this. Botulinum toxin is a successful alternative to conventional therapy for patients with chronic migraine, muscle spasms, reagent bladder, and hyperhidrosis. Additionally, it has been found that botulinum toxin is quite effective at reducing chronic pelvic discomfort in females with endometriosis. People who have undergone botulinum toxin therapy are able to maintain their mobility for as long as 11 months.

Increasing Demand For Minimal Invasion

botulinum toxin is utilized to treat a variety of aging-related problems, including crow's feet, glabellar lines, forehead lines, and others. People over 40 are therefore more likely to experience these indicators of aging. Therefore, botulinum toxin operations are becoming increasingly popular among people between the ages of 40 and 54. Among the most common non-invasive rejuvenation techniques, injectable botulinum toxin, soft-tissue fillers, as well as chemical peels each have particular uses for enhancing facial appearances.

Market Restraining Factors

Side Effects Related To The Use Of This Substance

Although botulinum toxin is typically regarded as safe when used in a clinical environment, it has the potential to have major negative effects. Botulinum toxin can most frequently be injected into the incorrect muscle group or over time can travel from the injection site, temporarily paralyzing undesired muscles. Unintentional paralysis of face muscles is the main cause of the side effects of cosmetic use. These include difficulty eating, muscle weakness, and partial facial paralysis.

Product Outlook

On the basis of Product, the Botulinum Toxin Market is bifurcated into Type A and Type B. In 2021, the Type-A segment witnessed the biggest revenue share of the botulinum toxin market. The increase in the growth of the market is attributed to the rise in the number of cases of sialorrhea all over the world. There are a number of commercially available botulinum toxin type-A medications, including Botox and Dysport, that have undergone clinical testing and have been shown to be both safe and effective over the long term with the fewest side effects.

Application Outlook

Based on Application, the Botulinum Toxin Market is divided into Therapeutic and Aesthetic. In 2021, the aesthetics segment recorded a significant revenue share of the botulinum toxin market. Botulinum toxin is a staple of the cosmetology toolbox. There have been more cosmetic procedures performed as a result of increased aesthetic consciousness and technology breakthroughs in both developed and developing nations.

End-User Outlook

By End-User, the Botulinum Toxin Market is segregated into Hospitals, Dermatology Clinics, and Spas & Cosmetic Centers. In 2021, the spas and cosmetic centers segment recorded a substantial revenue share of the botulinum toxin market. The segment's growth is primarily attributed to a higher inclination for aesthetic operations in dermatological clinics, spas, and cosmetic centers.

Botulinum Toxin Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 5.2 Billion
Market size forecast in 2028	USD 10.5 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 10.8% from 2022 to 2028
Number of Pages	162
Number of Tables	327
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Product, Application, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	High Levels Of Effectiveness And Efficiency In Therapeutic And Cosmetic Applications Increasing Demand For Minimal Invasion
Restraints	Side Effects Related To The Use Of This Substance

Regional Outlook

Region-Wise, the Botulinum Toxin Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America dominated the botulinum toxin market with the largest revenue share. The growth of regional market is expanding due to rising disposable income as well as an increase in cosmetic operations. Moreover, there is a significant number of market players operating in the region, who are increasing their focus and efforts in order to fulfill the rising demands of customers.

Free Valuable Insights: Global Botulinum Toxin Market size to reach USD 10.5 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Evolus, Inc. (Alphaeon Corporation), Merz Pharma GmbH & Co. KGaA, AbbVie, Inc., Ipsen Pharma, Galderma S.A., USWM, LLC, and Metabiologics, Inc. (Object Pharma).

Strategies deployed in Botulinum Toxin Market

• Jul-2021: Allergan plc, subsidiary of AbbVie, Inc. received the US FDA approval for its label expansion of BOTOX to include muscles in order to treat upper limb spasticity among adults. This acquisition aimed to complement the company's excellence in neurotoxin science and highlight the benefits of BOTOX in the treatment of upper limb spasticity.
• Nov-2020: Galderma expanded its geographical footprint in China with the launch of its Dysport. With this launch, the company aimed to highlight its commitment to introducing new innovations in the aesthetic market in order to grow while also fulfilling the demand of its customers across China.
• May-2020: AbbVie acquired Allergan, an American global pharmaceutical company. Under this acquisition, the company aimed to leverage growth prospects in neuroscience through the addition of Allergan's Botox therapeutics, Vraylar, and Ubrelvy.
• Oct-2019: Allergan plc, subsidiary of AbbVie, Inc. received the US FDA approval for its supplemental biologics license application for BOTOX to treat pediatric patients from age 2 years-17 years. This acquisition aimed to reinforce the approval of the 11th BOTOX therapeutic indication in the same year.
• Sep-2019: Ipsen received approval for expanded use of its Dysport for injection to provide treatment for upper limb spasticity among children of age 2 or older. Through this approval, the company aimed to complement its neurotoxin research legacy as well as its strategy to bring advancements in patient care.
• May-2019: Merz received European approval for the Xeomin, a symptomatic treatment option for chronic sialorrhea in adult patients. The new treatment aimed to aid patients in enhancing the quality of life of patients with sialorrhea.
• Feb-2019: Evolus received the US FDA approval for its Jeuveau. With the new Hi-Pure technology-built neurotoxin, the company aimed to offer enhanced aesthetics
• Jan-2018: Ipsen received approval for its DYSPORT THERAPEUTIC from Health Canada for the treatment of limb spasticity among pediatric patients in patients of age 2 or older. With this acquisition, the company aimed to offer a treatment that provides improved movement and stiffness.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Type A
• Type B

By Application

• Therapeutic
• Aesthetic

By End User

• Hospitals
• Dermatology Clinics
• Spas & Cosmetic Centers

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Evolus, Inc. (Alphaeon Corporation)
• Merz Pharma GmbH & Co. KGaA
• AbbVie, Inc.
• Ipsen Pharma
• Galderma S.A.
• USWM, LLC
• Metabiologics, Inc. (Object Pharma)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Botulinum Toxin Market, by Product
1.4.2 Global Botulinum Toxin Market, by Application
1.4.3 Global Botulinum Toxin Market, by End User
1.4.4 Global Botulinum Toxin Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Botulinum Toxin Market

Chapter 4. Global Botulinum Toxin Market by Product
4.1 Global Type A Market by Region
4.2 Global Type B Market by Region

Chapter 5. Global Botulinum Toxin Market by Application
5.1 Global Therapeutic Market by Region
5.2 Global Aesthetic Market by Region

Chapter 6. Global Botulinum Toxin Market by End User
6.1 Global Hospitals Market by Region
6.2 Global Dermatology Clinics Market by Region
6.3 Global Spas & Cosmetic Centers Market by Region

Chapter 7. Global Botulinum Toxin Market by Region
7.1 North America Botulinum Toxin Market
7.1.1 North America Botulinum Toxin Market by Product
7.1.1.1 North America Type A Market by Country
7.1.1.2 North America Type B Market by Country
7.1.2 North America Botulinum Toxin Market by Application
7.1.2.1 North America Therapeutic Market by Country
7.1.2.2 North America Aesthetic Market by Country
7.1.3 North America Botulinum Toxin Market by End User
7.1.3.1 North America Hospitals Market by Country
7.1.3.2 North America Dermatology Clinics Market by Country
7.1.3.3 North America Spas & Cosmetic Centers Market by Country
7.1.4 North America Botulinum Toxin Market by Country
7.1.4.1 US Botulinum Toxin Market
7.1.4.1.1 US Botulinum Toxin Market by Product
7.1.4.1.2 US Botulinum Toxin Market by Application
7.1.4.1.3 US Botulinum Toxin Market by End User
7.1.4.2 Canada Botulinum Toxin Market
7.1.4.2.1 Canada Botulinum Toxin Market by Product
7.1.4.2.2 Canada Botulinum Toxin Market by Application
7.1.4.2.3 Canada Botulinum Toxin Market by End User
7.1.4.3 Mexico Botulinum Toxin Market
7.1.4.3.1 Mexico Botulinum Toxin Market by Product
7.1.4.3.2 Mexico Botulinum Toxin Market by Application
7.1.4.3.3 Mexico Botulinum Toxin Market by End User
7.1.4.4 Rest of North America Botulinum Toxin Market
7.1.4.4.1 Rest of North America Botulinum Toxin Market by Product
7.1.4.4.2 Rest of North America Botulinum Toxin Market by Application
7.1.4.4.3 Rest of North America Botulinum Toxin Market by End User
7.2 Europe Botulinum Toxin Market
7.2.1 Europe Botulinum Toxin Market by Product
7.2.1.1 Europe Type A Market by Country
7.2.1.2 Europe Type B Market by Country
7.2.2 Europe Botulinum Toxin Market by Application
7.2.2.1 Europe Therapeutic Market by Country
7.2.2.2 Europe Aesthetic Market by Country
7.2.3 Europe Botulinum Toxin Market by End User
7.2.3.1 Europe Hospitals Market by Country
7.2.3.2 Europe Dermatology Clinics Market by Country
7.2.3.3 Europe Spas & Cosmetic Centers Market by Country
7.2.4 Europe Botulinum Toxin Market by Country
7.2.4.1 Germany Botulinum Toxin Market
7.2.4.1.1 Germany Botulinum Toxin Market by Product
7.2.4.1.2 Germany Botulinum Toxin Market by Application
7.2.4.1.3 Germany Botulinum Toxin Market by End User
7.2.4.2 UK Botulinum Toxin Market
7.2.4.2.1 UK Botulinum Toxin Market by Product
7.2.4.2.2 UK Botulinum Toxin Market by Application
7.2.4.2.3 UK Botulinum Toxin Market by End User
7.2.4.3 France Botulinum Toxin Market
7.2.4.3.1 France Botulinum Toxin Market by Product
7.2.4.3.2 France Botulinum Toxin Market by Application
7.2.4.3.3 France Botulinum Toxin Market by End User
7.2.4.4 Russia Botulinum Toxin Market
7.2.4.4.1 Russia Botulinum Toxin Market by Product
7.2.4.4.2 Russia Botulinum Toxin Market by Application
7.2.4.4.3 Russia Botulinum Toxin Market by End User
7.2.4.5 Spain Botulinum Toxin Market
7.2.4.5.1 Spain Botulinum Toxin Market by Product
7.2.4.5.2 Spain Botulinum Toxin Market by Application
7.2.4.5.3 Spain Botulinum Toxin Market by End User
7.2.4.6 Italy Botulinum Toxin Market
7.2.4.6.1 Italy Botulinum Toxin Market by Product
7.2.4.6.2 Italy Botulinum Toxin Market by Application
7.2.4.6.3 Italy Botulinum Toxin Market by End User
7.2.4.7 Rest of Europe Botulinum Toxin Market
7.2.4.7.1 Rest of Europe Botulinum Toxin Market by Product
7.2.4.7.2 Rest of Europe Botulinum Toxin Market by Application
7.2.4.7.3 Rest of Europe Botulinum Toxin Market by End User
7.3 Asia Pacific Botulinum Toxin Market
7.3.1 Asia Pacific Botulinum Toxin Market by Product
7.3.1.1 Asia Pacific Type A Market by Country
7.3.1.2 Asia Pacific Type B Market by Country
7.3.2 Asia Pacific Botulinum Toxin Market by Application
7.3.2.1 Asia Pacific Therapeutic Market by Country
7.3.2.2 Asia Pacific Aesthetic Market by Country
7.3.3 Asia Pacific Botulinum Toxin Market by End User
7.3.3.1 Asia Pacific Hospitals Market by Country
7.3.3.2 Asia Pacific Dermatology Clinics Market by Country
7.3.3.3 Asia Pacific Spas & Cosmetic Centers Market by Country
7.3.4 Asia Pacific Botulinum Toxin Market by Country
7.3.4.1 China Botulinum Toxin Market
7.3.4.1.1 China Botulinum Toxin Market by Product
7.3.4.1.2 China Botulinum Toxin Market by Application
7.3.4.1.3 China Botulinum Toxin Market by End User
7.3.4.2 Japan Botulinum Toxin Market
7.3.4.2.1 Japan Botulinum Toxin Market by Product
7.3.4.2.2 Japan Botulinum Toxin Market by Application
7.3.4.2.3 Japan Botulinum Toxin Market by End User
7.3.4.3 India Botulinum Toxin Market
7.3.4.3.1 India Botulinum Toxin Market by Product
7.3.4.3.2 India Botulinum Toxin Market by Application
7.3.4.3.3 India Botulinum Toxin Market by End User
7.3.4.4 South Korea Botulinum Toxin Market
7.3.4.4.1 South Korea Botulinum Toxin Market by Product
7.3.4.4.2 South Korea Botulinum Toxin Market by Application
7.3.4.4.3 South Korea Botulinum Toxin Market by End User
7.3.4.5 Singapore Botulinum Toxin Market
7.3.4.5.1 Singapore Botulinum Toxin Market by Product
7.3.4.5.2 Singapore Botulinum Toxin Market by Application
7.3.4.5.3 Singapore Botulinum Toxin Market by End User
7.3.4.6 Malaysia Botulinum Toxin Market
7.3.4.6.1 Malaysia Botulinum Toxin Market by Product
7.3.4.6.2 Malaysia Botulinum Toxin Market by Application
7.3.4.6.3 Malaysia Botulinum Toxin Market by End User
7.3.4.7 Rest of Asia Pacific Botulinum Toxin Market
7.3.4.7.1 Rest of Asia Pacific Botulinum Toxin Market by Product
7.3.4.7.2 Rest of Asia Pacific Botulinum Toxin Market by Application
7.3.4.7.3 Rest of Asia Pacific Botulinum Toxin Market by End User
7.4 LAMEA Botulinum Toxin Market
7.4.1 LAMEA Botulinum Toxin Market by Product
7.4.1.1 LAMEA Type A Market by Country
7.4.1.2 LAMEA Type B Market by Country
7.4.2 LAMEA Botulinum Toxin Market by Application
7.4.2.1 LAMEA Therapeutic Market by Country
7.4.2.2 LAMEA Aesthetic Market by Country
7.4.3 LAMEA Botulinum Toxin Market by End User
7.4.3.1 LAMEA Hospitals Market by Country
7.4.3.2 LAMEA Dermatology Clinics Market by Country
7.4.3.3 LAMEA Spas & Cosmetic Centers Market by Country
7.4.4 LAMEA Botulinum Toxin Market by Country
7.4.4.1 Brazil Botulinum Toxin Market
7.4.4.1.1 Brazil Botulinum Toxin Market by Product
7.4.4.1.2 Brazil Botulinum Toxin Market by Application
7.4.4.1.3 Brazil Botulinum Toxin Market by End User
7.4.4.2 Argentina Botulinum Toxin Market
7.4.4.2.1 Argentina Botulinum Toxin Market by Product
7.4.4.2.2 Argentina Botulinum Toxin Market by Application
7.4.4.2.3 Argentina Botulinum Toxin Market by End User
7.4.4.3 UAE Botulinum Toxin Market
7.4.4.3.1 UAE Botulinum Toxin Market by Product
7.4.4.3.2 UAE Botulinum Toxin Market by Application
7.4.4.3.3 UAE Botulinum Toxin Market by End User
7.4.4.4 Saudi Arabia Botulinum Toxin Market
7.4.4.4.1 Saudi Arabia Botulinum Toxin Market by Product
7.4.4.4.2 Saudi Arabia Botulinum Toxin Market by Application
7.4.4.4.3 Saudi Arabia Botulinum Toxin Market by End User
7.4.4.5 South Africa Botulinum Toxin Market
7.4.4.5.1 South Africa Botulinum Toxin Market by Product
7.4.4.5.2 South Africa Botulinum Toxin Market by Application
7.4.4.5.3 South Africa Botulinum Toxin Market by End User
7.4.4.6 Nigeria Botulinum Toxin Market
7.4.4.6.1 Nigeria Botulinum Toxin Market by Product
7.4.4.6.2 Nigeria Botulinum Toxin Market by Application
7.4.4.6.3 Nigeria Botulinum Toxin Market by End User
7.4.4.7 Rest of LAMEA Botulinum Toxin Market
7.4.4.7.1 Rest of LAMEA Botulinum Toxin Market by Product
7.4.4.7.2 Rest of LAMEA Botulinum Toxin Market by Application
7.4.4.7.3 Rest of LAMEA Botulinum Toxin Market by End User

Chapter 8. Company Profiles
8.1 Evolus, Inc. (Alphaeon Corporation)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Approvals and Trials:
8.2 Merz Pharma GmbH & Co. KGaA
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Approvals and Trials:
8.3 AbbVie, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.5.2 Approvals and Trials:
8.4 Ipsen Pharma
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Galderma S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Geographical Expansions:
8.6 USWM, LLC
8.6.1 Company Overview
8.7 Metabiologics, Inc. (Object Pharma, Inc.)
8.7.1 Company Overview

TABLE 1 Global Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 2 Global Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 3 Global Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 4 Global Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 5 Global Type A Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Type A Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Type B Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Type B Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 10 Global Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 11 Global Therapeutic Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Therapeutic Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Aesthetic Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Aesthetic Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 16 Global Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 17 Global Hospitals Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Hospitals Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Dermatology Clinics Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Dermatology Clinics Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Spas & Cosmetic Centers Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Spas & Cosmetic Centers Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Botulinum Toxin Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Botulinum Toxin Market by Region, 2022 - 2028, USD Million
TABLE 25 North America Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 26 North America Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 27 North America Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 28 North America Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 29 North America Type A Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Type A Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Type B Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Type B Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 34 North America Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 35 North America Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Aesthetic Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Aesthetic Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 40 North America Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 41 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Dermatology Clinics Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Dermatology Clinics Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Spas & Cosmetic Centers Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Spas & Cosmetic Centers Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Botulinum Toxin Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Botulinum Toxin Market by Country, 2022 - 2028, USD Million
TABLE 49 US Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 50 US Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 51 US Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 52 US Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 53 US Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 54 US Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 55 US Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 56 US Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 57 Canada Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 58 Canada Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 59 Canada Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 60 Canada Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 61 Canada Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 62 Canada Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 63 Canada Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 64 Canada Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 65 Mexico Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 66 Mexico Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 67 Mexico Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 68 Mexico Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 69 Mexico Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 70 Mexico Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 71 Mexico Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 72 Mexico Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 73 Rest of North America Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 74 Rest of North America Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 75 Rest of North America Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 76 Rest of North America Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 77 Rest of North America Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 78 Rest of North America Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 79 Rest of North America Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 80 Rest of North America Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 81 Europe Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 82 Europe Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 83 Europe Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 84 Europe Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 85 Europe Type A Market by Country, 2018 - 2021, USD Million
TABLE 86 Europe Type A Market by Country, 2022 - 2028, USD Million
TABLE 87 Europe Type B Market by Country, 2018 - 2021, USD Million
TABLE 88 Europe Type B Market by Country, 2022 - 2028, USD Million
TABLE 89 Europe Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 90 Europe Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 91 Europe Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 92 Europe Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 93 Europe Aesthetic Market by Country, 2018 - 2021, USD Million
TABLE 94 Europe Aesthetic Market by Country, 2022 - 2028, USD Million
TABLE 95 Europe Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 96 Europe Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 97 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 98 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 99 Europe Dermatology Clinics Market by Country, 2018 - 2021, USD Million
TABLE 100 Europe Dermatology Clinics Market by Country, 2022 - 2028, USD Million
TABLE 101 Europe Spas & Cosmetic Centers Market by Country, 2018 - 2021, USD Million
TABLE 102 Europe Spas & Cosmetic Centers Market by Country, 2022 - 2028, USD Million
TABLE 103 Europe Botulinum Toxin Market by Country, 2018 - 2021, USD Million
TABLE 104 Europe Botulinum Toxin Market by Country, 2022 - 2028, USD Million
TABLE 105 Germany Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 106 Germany Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 107 Germany Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 108 Germany Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 109 Germany Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 110 Germany Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 111 Germany Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 112 Germany Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 113 UK Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 114 UK Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 115 UK Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 116 UK Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 117 UK Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 118 UK Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 119 UK Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 120 UK Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 121 France Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 122 France Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 123 France Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 124 France Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 125 France Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 126 France Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 127 France Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 128 France Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 129 Russia Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 130 Russia Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 131 Russia Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 132 Russia Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 133 Russia Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 134 Russia Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 135 Russia Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 136 Russia Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 137 Spain Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 138 Spain Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 139 Spain Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 140 Spain Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 141 Spain Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 142 Spain Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 143 Spain Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 144 Spain Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 145 Italy Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 146 Italy Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 147 Italy Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 148 Italy Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 149 Italy Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 150 Italy Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 151 Italy Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 152 Italy Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 153 Rest of Europe Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 154 Rest of Europe Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 155 Rest of Europe Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 156 Rest of Europe Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 157 Rest of Europe Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 158 Rest of Europe Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 159 Rest of Europe Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 160 Rest of Europe Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 161 Asia Pacific Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 162 Asia Pacific Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 163 Asia Pacific Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 164 Asia Pacific Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 165 Asia Pacific Type A Market by Country, 2018 - 2021, USD Million
TABLE 166 Asia Pacific Type A Market by Country, 2022 - 2028, USD Million
TABLE 167 Asia Pacific Type B Market by Country, 2018 - 2021, USD Million
TABLE 168 Asia Pacific Type B Market by Country, 2022 - 2028, USD Million
TABLE 169 Asia Pacific Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 170 Asia Pacific Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 171 Asia Pacific Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 172 Asia Pacific Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 173 Asia Pacific Aesthetic Market by Country, 2018 - 2021, USD Million
TABLE 174 Asia Pacific Aesthetic Market by Country, 2022 - 2028, USD Million
TABLE 175 Asia Pacific Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 176 Asia Pacific Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 177 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 178 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Dermatology Clinics Market by Country, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Dermatology Clinics Market by Country, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Spas & Cosmetic Centers Market by Country, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Spas & Cosmetic Centers Market by Country, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Botulinum Toxin Market by Country, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Botulinum Toxin Market by Country, 2022 - 2028, USD Million
TABLE 185 China Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 186 China Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 187 China Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 188 China Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 189 China Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 190 China Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 191 China Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 192 China Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 193 Japan Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 194 Japan Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 195 Japan Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 196 Japan Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 197 Japan Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 198 Japan Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 199 Japan Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 200 Japan Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 201 India Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 202 India Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 203 India Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 204 India Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 205 India Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 206 India Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 207 India Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 208 India Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 209 South Korea Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 210 South Korea Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 211 South Korea Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 212 South Korea Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 213 South Korea Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 214 South Korea Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 215 South Korea Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 216 South Korea Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 217 Singapore Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 218 Singapore Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 219 Singapore Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 220 Singapore Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 221 Singapore Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 222 Singapore Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 223 Singapore Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 224 Singapore Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 225 Malaysia Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 226 Malaysia Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 227 Malaysia Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 228 Malaysia Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 229 Malaysia Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 230 Malaysia Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 231 Malaysia Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 232 Malaysia Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 233 Rest of Asia Pacific Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 234 Rest of Asia Pacific Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 235 Rest of Asia Pacific Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 236 Rest of Asia Pacific Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 237 Rest of Asia Pacific Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 238 Rest of Asia Pacific Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 239 Rest of Asia Pacific Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 240 Rest of Asia Pacific Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 241 LAMEA Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 242 LAMEA Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 243 LAMEA Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 244 LAMEA Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 245 LAMEA Type A Market by Country, 2018 - 2021, USD Million
TABLE 246 LAMEA Type A Market by Country, 2022 - 2028, USD Million
TABLE 247 LAMEA Type B Market by Country, 2018 - 2021, USD Million
TABLE 248 LAMEA Type B Market by Country, 2022 - 2028, USD Million
TABLE 249 LAMEA Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 250 LAMEA Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 251 LAMEA Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 252 LAMEA Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 253 LAMEA Aesthetic Market by Country, 2018 - 2021, USD Million
TABLE 254 LAMEA Aesthetic Market by Country, 2022 - 2028, USD Million
TABLE 255 LAMEA Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 256 LAMEA Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 257 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 258 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 259 LAMEA Dermatology Clinics Market by Country, 2018 - 2021, USD Million
TABLE 260 LAMEA Dermatology Clinics Market by Country, 2022 - 2028, USD Million
TABLE 261 LAMEA Spas & Cosmetic Centers Market by Country, 2018 - 2021, USD Million
TABLE 262 LAMEA Spas & Cosmetic Centers Market by Country, 2022 - 2028, USD Million
TABLE 263 LAMEA Botulinum Toxin Market by Country, 2018 - 2021, USD Million
TABLE 264 LAMEA Botulinum Toxin Market by Country, 2022 - 2028, USD Million
TABLE 265 Brazil Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 266 Brazil Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 267 Brazil Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 268 Brazil Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 269 Brazil Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 270 Brazil Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 271 Brazil Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 272 Brazil Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 273 Argentina Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 274 Argentina Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 275 Argentina Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 276 Argentina Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 277 Argentina Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 278 Argentina Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 279 Argentina Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 280 Argentina Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 281 UAE Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 282 UAE Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 283 UAE Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 284 UAE Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 285 UAE Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 286 UAE Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 287 UAE Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 288 UAE Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 289 Saudi Arabia Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 290 Saudi Arabia Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 291 Saudi Arabia Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 292 Saudi Arabia Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 293 Saudi Arabia Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 294 Saudi Arabia Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 295 Saudi Arabia Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 296 Saudi Arabia Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 297 South Africa Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 298 South Africa Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 299 South Africa Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 300 South Africa Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 301 South Africa Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 302 South Africa Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 303 South Africa Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 304 South Africa Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 305 Nigeria Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 306 Nigeria Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 307 Nigeria Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 308 Nigeria Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 309 Nigeria Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 310 Nigeria Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 311 Nigeria Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 312 Nigeria Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 313 Rest of LAMEA Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 314 Rest of LAMEA Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 315 Rest of LAMEA Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 316 Rest of LAMEA Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 317 Rest of LAMEA Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 318 Rest of LAMEA Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 319 Rest of LAMEA Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 320 Rest of LAMEA Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 321 Key information – Evolus, Inc.
TABLE 322 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 323 Key information – AbbVie, Inc.
TABLE 324 Key Information – Ipsen Pharma
TABLE 325 Key Information – Galderma S.A.
TABLE 326 Key Information – USWM, LLC
TABLE 327 Key Information – Metabiologics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Botulinum Toxin Market Share by Product, 2021
FIG 3 Global Botulinum Toxin Market Share by Product, 2028
FIG 4 Global Botulinum Toxin Market by Product, 2018 - 2028, USD Million
FIG 5 Global Botulinum Toxin Market Share by Application, 2021
FIG 6 Global Botulinum Toxin Market Share by Application, 2028
FIG 7 Global Botulinum Toxin Market by Application, 2018 - 2028, USD Million
FIG 8 Global Botulinum Toxin Market Share by End User, 2021
FIG 9 Global Botulinum Toxin Market Share by End User, 2028
FIG 10 Global Botulinum Toxin Market by End User, 2018 - 2028, USD Million
FIG 11 Global Botulinum Toxin Market Share by Region, 2021
FIG 12 Global Botulinum Toxin Market Share by Region, 2028
FIG 13 Global Botulinum Toxin Market by Region, 2018 - 2028, USD Million
FIG 14 Recent strategies and developments: AbbVie, Inc.